What does Abiomed invest in?
Abiomed invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Pharmaceutical, Software and Health Care.

United States · Investor
Last cheque observed Dec 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCorporate VC
3 rounds on record
Mostly Series A and Series B: 67% of its rounds
Every round we can evidence, newest first3 appearances
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Acquisitions by the firm itself
The latest companies Abiomed put money into.
Abiomed invests most often at Series A and Series B (67% of the rounds on record), in sectors such as Pharmaceutical, Software and Health Care.
3 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2019.
Its most recent investments on record: Impule Dynamics (Series D, Dec 2019), Protembis (Series A, Oct 2018) and Magent Medical (Series B, Sept 2017).
The median round it joins is $15M.
No investments in the last 12 months; the latest was in Dec 2019.
Abiomed is a corporate VC based in Danvers, United States.
Abiomed was founded in 1981.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it